SE385587B - Forfarande for framstellning av tvakomponentkomplex - Google Patents

Forfarande for framstellning av tvakomponentkomplex

Info

Publication number
SE385587B
SE385587B SE7207893A SE789372A SE385587B SE 385587 B SE385587 B SE 385587B SE 7207893 A SE7207893 A SE 7207893A SE 789372 A SE789372 A SE 789372A SE 385587 B SE385587 B SE 385587B
Authority
SE
Sweden
Prior art keywords
procedure
manufacture
component complex
complex
component
Prior art date
Application number
SE7207893A
Other languages
English (en)
Swedish (sv)
Inventor
K-H Scheit
P Faerber
K Reuss
O Saiko
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712130544 external-priority patent/DE2130544A1/de
Priority claimed from DE19722218057 external-priority patent/DE2218057A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SE385587B publication Critical patent/SE385587B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7207893A 1971-06-19 1972-06-15 Forfarande for framstellning av tvakomponentkomplex SE385587B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712130544 DE2130544A1 (de) 1971-06-19 1971-06-19 Zweikomponenten-Komplexe mit biologischer Wirkung
DE19722218057 DE2218057A1 (de) 1972-04-14 1972-04-14 Zweikomponenten-komplexe mit biologischer wirkung

Publications (1)

Publication Number Publication Date
SE385587B true SE385587B (sv) 1976-07-12

Family

ID=25761303

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7207893A SE385587B (sv) 1971-06-19 1972-06-15 Forfarande for framstellning av tvakomponentkomplex
SE7415908A SE7415908L (xx) 1971-06-19 1974-12-18

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7415908A SE7415908L (xx) 1971-06-19 1974-12-18

Country Status (12)

Country Link
US (1) US3843629A (xx)
AU (1) AU467984B2 (xx)
BE (1) BE785012A (xx)
CA (1) CA988082A (xx)
CH (1) CH584719A5 (xx)
DD (1) DD100718A5 (xx)
ES (1) ES404001A1 (xx)
FR (1) FR2143060B1 (xx)
GB (1) GB1364987A (xx)
IL (1) IL39649A (xx)
NL (1) NL7207984A (xx)
SE (2) SE385587B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US3952097A (en) * 1974-09-27 1976-04-20 The United States Of America As Represented By The Department Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
JPS62252798A (ja) * 1986-01-06 1987-11-04 Nippon Shinyaku Co Ltd 核酸誘導体
WO1989002921A1 (en) * 1987-09-22 1989-04-06 Temple University Artificial dna base pair analogues
US4882147A (en) * 1987-12-16 1989-11-21 The Research Foundation Of State University Of New York Novel polynucleotide analogs, methods for inhibiting nucleic acid polymerases and methods for inducing synthesis of interferon
US7439349B2 (en) * 2002-07-03 2008-10-21 Andres Salazar Method for preparation of large volume batches of poly-ICLC with increased biological potency; therapeutic, clinical and veterinary uses thereof

Also Published As

Publication number Publication date
FR2143060A1 (xx) 1973-02-02
AU467984B2 (en) 1973-12-20
IL39649A (en) 1975-12-31
NL7207984A (xx) 1972-12-21
SE7415908L (xx) 1974-12-18
ES404001A1 (es) 1975-11-16
BE785012A (fr) 1972-12-18
DD100718A5 (xx) 1973-10-05
CA988082A (en) 1976-04-27
CH584719A5 (xx) 1977-02-15
AU4347272A (en) 1973-12-20
GB1364987A (en) 1974-08-29
FR2143060B1 (xx) 1975-06-20
IL39649A0 (en) 1972-08-30
US3843629A (en) 1974-10-22

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE432102B (sv) Forfarande for framstellning av estrar av penicilliner
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
NO140478C (no) Fremgangsmaate for fremstilling av fibriller
SE401186B (sv) Forfarande for framstellning av nya penicilliner
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE417969B (sv) Forfarande for framstellning av 3-metylencefalosporinforeningar
FI55098B (fi) Anordning foer inspektion av innerytan av en reaktortank i en kaernreaktor
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE385587B (sv) Forfarande for framstellning av tvakomponentkomplex
SE391332B (sv) Forfarande for framstellning av en fenyletanolamin
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE393616B (sv) Forfarande for framstellning av dihydrokodein
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE384381B (sv) Forfarande for kontinuerlig framstellning av ferrokisel
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE387948B (sv) Forfarande for framstellning av tiofen